EKSO (Ekso Bionics Holdings, Inc. Common Stock) Stock Analysis - AI Report
Ekso Bionics Holdings, Inc. Common Stock (EKSO) is a publicly traded Healthcare sector company. As of May 21, 2026, EKSO trades at $11.80 with a market cap of $42.05M and a P/E ratio of -2.40. EKSO moved -3.56% today. Year to date, EKSO is +151.06%; over the trailing twelve months it is +62.87%. Its 52-week range spans $2.73 to $18.15. Rallies surfaces EKSO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What is the AI research view on EKSO?
Rallies AI research for EKSO combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
Jones Jason C bought 1.31K (~$15.50K) on Mar 16, 2026.
Wong Jerome bought 1.31K (~$15.50K) on Mar 16, 2026.
ASHER DANIEL bought 15.54K (~$191.16K) on Feb 19, 2026.
EKSO Analyst Consensus
EKSO analyst coverage data. Average price target: $0.00.
Common questions about EKSO
What is the AI research view on EKSO?
Rallies AI research for EKSO combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
What data powers the Rallies AI report for EKSO?
Rallies AI research for EKSO combines live market data, financials, news, analyst context, hedge fund ownership, politician disclosures, insider activity, and risk factors.
Is EKSO research on Rallies investment advice?
No. Rallies provides research, data, and educational context for EKSO. It does not provide personalized investment advice.
